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diac troponin T type-2 (TNNT2). We examined polymorphisms of the
TNNT2 gene in a Kazak family from Xinjiang, China, and in idiopathic
DCM (IDCM) patients of both Kazak and Han ethnicity.
METHODS Peripheral blood samples were collected from 9 members
of the FDCM, from 180 patients with IDCM (90 Kazak and 90 Han), and
180 healthy controls (90 Kazak and 90 Han). PCR was used to amplify
15 exons and nearby introns of the TNNT2 gene. The ampliﬁed prod-
ucts were sequenced and compared to the standard sequence in
Pubmed by BLAST and CHROMAS software, to identify mutation sites.
RESULTS IDCM from Kazak and Han were complied for Hardy-Weinberg
equilibrium. There was a signiﬁcant difference in the genotype distribu-
tion (c2 ¼6.67, P ¼0.015) and allele frequency (c2 ¼5.17, P ¼0.0017) be-
tween Kazaks with IDCM and Kazak controls of SNP rs3729547.
Meanwhile, it also has a difference in the genotype distribution (c2 ¼7.62,
P ¼0.022) and allele frequency (c2 ¼6.73, P ¼0.009) between Han with
IDCM and Han controls, but the rate of IDCM was descend. A novel
variant (c.617G > T) was identiﬁed in one FDCM patient at exon 13, this
mutation caused an amino acid substitution.
CONCLUSIONS The TNNT2 SNP rs3729547 is not only a possible in-
dependent risk factor for Han ethnicity, but also for Kazak ethnicity.
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OBJECTIVES To investigate the immediate and short-term thera-
peutic efﬁcacy and feasibility of coil embolization of a targeted septal
artery in patients with hypertrophic obstructive cardiomyopathy
(HOCM).
METHODS Four patients with hypertrophic obstructive cardiomyop-
athy refractory to medication were chosen, and treated with coil
embolization of a targeted septal artery. Preoperative, intraoperative
and postoperative left ventricular outﬂow tract pressure gradient
(LVOTPG), septal thickness and systolic anterior motion of mitral
(SAM) phenomenon were compared. Postoperative complications and
improvement of clinical symptoms were observed.
RESULTS Embolization of the targeted septal branch was successfully
performed in 4 patients. Compared with preoperative LVOTPG of
patients after balloon pressure and complete occlusion were signiﬁ-
cantly lower(92.5026.30 vs. 38.006.93 and 28.256.24 mmHg;
P <0.05, respectively). The average septal thickness of patients at one
month after operation was not statistically signiﬁcant difference
compared with the preoperative value(18.402.36 vs. 18.682.42 mm;
P >0.05, respectively). Follow-up of the 4 cases at 1 month after
operation revealed remarkable attenuation of SAM phenomenon. We
did not detect ventricular tachycardia and atrioventricular block.
Postoperative NYHA classiﬁcation were signiﬁcantly lower than
baseline (3.000.82 vs. 1.500.58; P <0.05, respectively).
CONCLUSIONS The study showed treatment for hypertrophic obstruc-
tive cardiomyopathy by coil embolization of a targeted septal artery is
feasible.In the treatment of HOCM, coil embolization of a targeted septal
artery can signiﬁcantly reduce LVOTPG and improve clinical symptoms.
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OBJECTIVES Recent studies have shown that smoking and drinking
are associated with poorer outcomes in patients with cardiomyopa-
thy. The purpose of this study was to determine all-cause mortality in
dilated cardiomyopathy (DCM) associated with smoking and drinking.METHODS An observational cohort study was undertaken in DCM pa-
tients from November 2003 to September 2011. A total of 1118 patients
were enrolled, with a mean follow-up of 3.52.3 years. Standard de-
mographics were obtained, and transthoracic echocardiography and
routine blood testing were performed shortly after admission. Outcome
assessment was based on the all-cause death after admission.
RESULTS The patients were divided into three groups: non-smokers
(n ¼593), mild to moderate smokers (n ¼159) and heavy smokers
(n ¼366). The all-cause mortality rates showed no differences between
the three groups (23.8%, 20.8% and 24%, respectively; log-rank c2 ¼1.281,
P ¼0.527). There was also no signiﬁcant difference in mortality between
non-drinkers (n ¼747), mild drinkers (n ¼142) and moderate drinkers
(n ¼229) (23.7%, 23.2% and 22.3%, respectively; log-rank c2 ¼2.343,
P ¼0.310). In the Cox analysis, neither the smoking (HR 0.971, P ¼0.663)
nor the drinking status (HR 0.891, P ¼0.140) was a signiﬁcant indepen-
dent predictor of all-cause mortality in patients with DCM.
CONCLUSIONS In conclusion, there were no signiﬁcant differences in
mortality between the smoking- and drinking-related patient groups,
indicating no effect of smoking and drinking on all-cause mortality in
patients with DCM in the present large-scale study.
GW26-e0787
Correlation between Tei index and B-natriuretic peptide in dilated
cardiomyopathy patients
Xuewei Chang,1 Shouyan Zhang,1 Yajuan Fan,2 Yidong Wei,3
Jinghan Wei4
1Department of Cardiology, Luoyang Central Hospital, afﬁliated to
Zhengzhou University; 2Department of Ultrasound, Luoyang Central
Hospital, afﬁliated to Zhengzhou University; 3Department of
Cardiology, Shanghai Tenth People’s Hospital, afﬁliated to tongji
University; 4Department of Cardiology, The ﬁrst afﬁliated hospital of
Zhengzhou University
OBJECTIVES The growing number of heart failure patients is becoming
an important issue in cardiology. B-natriuretic peptide (BNP) is a recog-
nized marker of heart failure, including in patients with dilated cardio-
myopathy. The Tei index is an indicator of left ventricular function. The
aim of the study was to evaluate the relationship between Tei index and
the concentration of plasma BNP in dilated cardiomyopathy patients.
METHODS Fifty patients with dilated cardiomyopathy were enrolled
in the study. Fifty healthy individuals were assigned to the control
group. BNP was measured by enzyme linked immunosorbent assay
(ELISA). Echocardiography was performed to calculate Tei index.
RESULTS Median value of BNP in patients with dilated cardiomyop-
athy was 1086.1 pg/ml, and 42.8 pg/ml in control group (p < 0.05). The
median value of the Tei index was 0.80 in patients with dilated car-
diomyopathy, 0.30 in individuals with control group. LVEDD, LVESD
were signiﬁcantly higher in dilated cardiomyopathy patients also. All
the differences were statistically signiﬁcant (p < 0.05). A signiﬁcant
positive correlation (R¼0.401, p < 0.05) between BNP and the TEI
index was found. The stepwise regression analysis showed closer
relationship existing in Tei index and BNP.
CONCLUSIONS Tei index, BNP was signiﬁcantly increased in dilated
cardiomyopathy patients. There was a signiﬁcant positive correlation
between them. Tei index was a better index to estimate ventricular
global function than other conventional indices.
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OBJECTIVES To evaluate the feasibility and the safety after non-
surgical septal myocardial reduction by coil embolization in hyper-
trophic obstructive cardiomyopathy (HOCM).
METHODS Thirteen patients (pts) (male: 5 pts; mean age: 48 (10 years)
with HOCM and drug-refractory symptoms underwent ablation of
septal hypertrophy by coil embolization with detachable coils. The
Tornado coils (Cook Inc, Bloomington, IN, USA), 3 or 4mm in diam-
eter and 2 or 3cm in length, were delivered through a 3F RenegadeTM
Hi-Flo microcatheter (Boston Scientiﬁc Scimed, Maple Grove, MN,
USA) positioned inside the target vessel as distally as possible. One or
more straight coils were used for each target vessel until complete
ﬂow obstruction was noted. The intraventricular pressure gradient
